Cardiovascular risk factors in 2011 and secular trends since 2007: The Cardiovascular Risk in Young Finns Study

Scandinavian Journal of Public Health

Volumn 42, Issue 7, 2014, Pages 563-571

  Nuotio, Joel ^a   Oikonen, Mervi ^a   Magnussen, Costan G ^b   Jokinen, Eero ^c   Laitinen, Tomi ^d   Hutri Kähönen, Nina ^e   Kähönen, Mika ^e   Lehtimäki, Terho ^e   Taittonen, Leena ^f   Tossavainen, Päivi ^g   Jula, Antti ^h   Loo, Britt Marie ⁱ   Viikari, Jorma S ⁱ   Juonala, Markus ⁱ   Raitakari, Olli T ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^f VAASA CENTRAL HOSPITAL   (Finland)

^g UNIVERSITY OF OULU   (Finland)

^h NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

ⁱ TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Cardiovascular; risk factors; secular trend

Indexed keywords

TRIACYLGLYCEROL;

ADULT; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FEMALE; FINLAND; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; RISK FACTOR; SEX RATIO; WAIST CIRCUMFERENCE;

ADULT; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SEX DISTRIBUTION; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84908875403     PISSN: 14034948     EISSN: 16511905     Source Type: Journal    
DOI: 10.1177/1403494814541597     Document Type: Article

References (30)

1. Puska P. Vartiainen E. Tuomilehto J. et al. Changes in premature deaths in Finland: successful long-term prevention of cardiovascular diseases. Bull World Health Organ 1998;76:419–25.
2. Vartiainen E. Laatikainen T. Peltonen M. et al. Thirty-five-year trends in cardiovascular risk factors in Finland. Int J Epidemiol 2010;39:504–18.
3. Vartiainen E. Jousilahti P. Alfthan G. et al. Cardiovascular risk factor changes in Finland, 1972–1997. Int J Epidemiol 2000;29:49–56.
4. Valsta L.M. Tapanainen H. Sundvall J. et al. Explaining the 25-year decline of serum cholesterol by dietary changes and use of lipid-lowering medication in Finland. Public Health Nutr 2010;13:932–8.
5. Ng N. Johnson O. Lindahl B. et al. A reversal of decreasing trends in population cholesterol levels in Vasterbotten County, Sweden. Glob Health Action 2012;5. doi:10.3402/gha.v5i0.10367. Epub 23 March 2012.
6. Vartiainen E. Borodulin K. Sundvall J. et al. FINRISKI-tutkimus: Väestön kolesterolitaso on vuosikymmenien laskun jälkeen kääntynyt nousuun. [Cholesterol levels in the Finnish population have increased after decades of decline]. Finnish. Suom Lääkäril 2012;67:2365–8.
7. Lahti-Koski M. Seppänen-Nuijten E. Männistö S. et al. Twenty-year changes in the prevalence of obesity among Finnish adults. Obes Rev 2010 Mar;11:171–6.
8. Lobstein T. Baur L. Uauy R., IASO International Obesity Task Force. Obesity in children and young people: a crisis in public health. Obes Rev 2004;5 (Suppl 1):4–104.
9. Lammi N. Blomstedt P.A. Moltchanova E. et al. Marked temporal increase in the incidence of type 1 and type 2 diabetes among young adults in Finland. Diabetologia 2008;51:897–9.
10. Danaei G. Finucane M.M. Lu Y. et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011;378:31–40.
11. Raitakari O.T. Juonala M. Rönnemaa T. et al. Cohort profile: the cardiovascular risk in Young Finns Study. Int J Epidemiol 2008;37:1220–6.
12. Kostner G.M. Letter: Enzymatic determination of cholesterol in high-density lipoprotein fractions prepared by polyanion precipitation. Clin Chem 1976;22:695.
13. Alberti K.G. Eckel R.H. Grundy S.M. et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640–5.
14. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2013;36 Suppl 1:S67–S74
15. Farzadfar F. Finucane M.M. Danaei G. et al. National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants. Lancet 2011;377:578–86.
16. Vartiainen E. Laatikainen T. Tapanainen H. et al. Suomalaisten sydän- ja verisuonitautien riskitekijät FINRISKI-tutkimuksessa 1982–2002. [Cardiovascular risk factor levels in the Finnish population between 1982–2002. FINRISKI-study.] Finnish. Suom Lääkäril 2003;58:4099–105.
17. Juonala M. Viikari J.S. Hutri-Kähönen N. et al. The 21-year follow-up of the Cardiovascular Risk in Young Finns Study: risk factor levels, secular trends and east-west difference. J Intern Med 2004;255:457–68.
18. Raiko J.R. Viikari J.S. Ilmanen A. et al. Follow-ups of the Cardiovascular Risk in Young Finns Study in 2001 and 2007: levels and 6-year changes in risk factors. J Intern Med 2010;267:370–84.
19. Helakorpi S. Holstila A. Virtanen S. et al. Suomalaisen aikuisväestön terveyskäyttäytyminen ja terveys, kevät 2011. [Health Behavior and Health among the Finnish Adult Population, Spring 2011]. Helsinki: Terveyden ja hyvinvoinnin laitos, 2012.
20. Brewer H.B. Jr. Hypertriglyceridemia: changes in the plasma lipoproteins associated with an increased risk of cardiovascular disease. Am J Cardiol 1999 May;83:3F–12F.
21. Pekkanen J. Linn S. Heiss G. et al. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med 1990;322:1700–7.
22. Lehto H.R. Lehto S. Havulinna A.S. et al. Gender differences in the prevalence, causes and treatment of high cardiovascular risk: findings from the FINRISK Survey. Eur J Prev Cardiol 2012;19:1153–60.
23. Laatikainen T. Jula A. Kastarinen M. et al. Verenpainetasot ja hoitotasapaino FINRISKI-tutkimusalueilla 1982–2012. [Blood pressure levels and therapeutic balance in FINRISK study areas in 1982–2012]. Finnish. Suom Lääkäril 2013;68:1803–9.
24. Järvi U. Suomalaisten lihominen pysähtyi. [Weight gaining of Finnish people stopped]. Finnish. Suom Lääkäril 2013;68:292.
25. Rokholm B. Baker J.L. Sørensen T.I. The levelling off of the obesity epidemic since the year 1999 – a review of evidence and perspectives. Obes Rev 2010;11:835–46.
26. Flint A.J. Rexrode K.M. Hu F.B. et al. Body mass index, waist circumference, and risk of coronary heart disease: a prospective study among men and women. Obes Res Clin Pract 2010;4:e171–e181.
27. Siren R. Eriksson J.G. Vanhanen H. Waist circumference a good indicator of future risk for type 2 diabetes and cardiovascular disease. BMC Public Health 2012;12:631–2458–12–631.
28. Pajunen P. Keinänen-Kiukaanniemi S. Korpi-Hyövälti E. et al. Ylipainon ja lihavuuden esiintyvyys tyypin 2 diabetespotilailla. [Prevalence of overweight and obesity in patients with type 2 diabetes in Finland]. Finnish. Suom Lääkäril 2012;38:2621–6.
29. Shimazaki T. Kadowaki T. Ohyama Y. et al. Hemoglobin A1c (HbA1c) predicts future drug treatment for diabetes mellitus: a follow-up study using routine clinical data in a Japanese university hospital. Transl Res 2007;149:196–204.
30. Andersson C. van Gaal L. Caterson I.D. et al. Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes. Diabetologia 2012;55:2348–55.